NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2024-10-14 liwei18868 来自广西

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤学;营养
经验分享：PEER REVIEW
14 May 2024
With Editor
18 September 2024
Out for Review
18 September 2024
Decision Pending
18 September 2024
Revision Required
08 October 2024
Revision Incomplete
08 October 2024
Revised Manuscript Submitted
08 October 2024
With Journal Administrator
14 October 2024
Accepted

今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2023-09-21 ms898308530249 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：药理
经验分享：09 January 2023
Manuscript Resubmitted
09 January 2023
With Journal Administrator
PEER REVIEW
28 December 2022
Ready to Revise
29 December 2022
Resubmission Incomplete
29 December 2022
Revised Manuscript Submitted
18 January 2023
With Editor
16 February 2023
Out for Review
21 February 2023
Decision Pending
24 February 2023
Revision Required
14 March 2023
Revision Incomplete
14 March 2023
Revised Manuscript Submitted
14 March 2023
With Journal Administrator
16 March 2023
With Editor
16 March 2023
Out for Review
06 April 2023
Decision Pending
09 April 2023
Revision Required
11 April 2023
Revision Incomplete
11 April 2023
Revised Manuscript Submitted
11 April 2023
With Journal Administrator
19 April 2023
Accepted

109 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2023-08-03 ms4000001156703951 来自河南省

11 May 2023 With Editor
14 June 2023 Out for review
02 August 2023 Decision Pending
02 August 2023 Rejected
等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2023-06-01 ms4000001156703951 来自河南省

请问Out for Review多久会有消息呢，着急

108 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2023-07-03 ms4000001156703951 来自河南省

请问meta类文章一般out for review多久会有消息呢

96 0

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2022-12-09 ms1000002133818494 来自四川省

审稿速度:6.0 | 投稿命中率:75.0
经验分享：20 August 2022 Submission Created
21 August 2022 Manuscript Submitted
21 August 2022 With Journal Administrator
22 August 2022 Submission Returned to Author
22 August 2022 Manuscript Resubmitted
22 August 2022 With Journal Administrator
24 August 2022 Ready to Revise
31 August 2022 Revised Manuscript Submitted
02 September 2022 Submission Returned to Author
03 September 2022 Manuscript Resubmitted
03 September 2022 With Journal Administrator
21 September 2022 With Editor
20 October 2022 Out for Review
20 October 2022 Decision Pending
26 October 2022 Revision Required
24 November 2022 Revised Manuscript Submitted
24 November 2022 With Journal Administrator
28 November 2022 With Editor
29 November 2022 Out for Review
07 December 2022 Decision Pending
07 December 2022 Accepted

85 0

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2022-03-19 ms5000000220509307

偏重的研究方向：肿瘤;meta-analysis
经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……

124 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2022-11-11 zyl1997

已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2020-09-11 unciawang

审稿速度:3.0 | 投稿命中率:75.0
经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。

263 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2230924, encodeId=3774223092481, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;营养 经验分享：PEER REVIEW 14 May 2024 With Editor 18 September 2024 Out for Review 18 September 2024 Decision Pending 18 September 2024 Revision Required 08 October 2024 Revision Incomplete 08 October 2024 Revised Manuscript Submitted 08 October 2024 With Journal Administrator 14 October 2024 Accepted 今年5月投稿，一直没有外送review，直到9月份才送出去review，我自己也忘记了，9月18号通知revison,提的问题不算尖锐，小改之后10月14号accept。文章仍然有一定投稿难度，总体印象不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220605/3edc92e78147435ebf6f452d3e3f56b1/d10cdc954a7b445880714c4b6f2a52c2.JPG, createdBy=21bb2866248, createdName=liwei18868, createdTime=Mon Oct 14 23:11:06 CST 2024, time=2024-10-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：09 January 2023 Manuscript Resubmitted 09 January 2023 With Journal Administrator PEER REVIEW 28 December 2022 Ready to Revise 29 December 2022 Resubmission Incomplete 29 December 2022 Revised Manuscript Submitted 18 January 2023 With Editor 16 February 2023 Out for Review 21 February 2023 Decision Pending 24 February 2023 Revision Required 14 March 2023 Revision Incomplete 14 March 2023 Revised Manuscript Submitted 14 March 2023 With Journal Administrator 16 March 2023 With Editor 16 March 2023 Out for Review 06 April 2023 Decision Pending 09 April 2023 Revision Required 11 April 2023 Revision Incomplete 11 April 2023 Revised Manuscript Submitted 11 April 2023 With Journal Administrator 19 April 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor 14 June 2023 Out for review 02 August 2023 Decision Pending 02 August 2023 Rejected 等了很久，等了这个结果超级难过，本来对这个期刊抱有很大的希望，现在都开始自我怀疑了，以上的时间进度希望给大家一个参考，我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：20 August 2022 Submission Created 21 August 2022 Manuscript Submitted 21 August 2022 With Journal Administrator 22 August 2022 Submission Returned to Author 22 August 2022 Manuscript Resubmitted 22 August 2022 With Journal Administrator 24 August 2022 Ready to Revise 31 August 2022 Revised Manuscript Submitted 02 September 2022 Submission Returned to Author 03 September 2022 Manuscript Resubmitted 03 September 2022 With Journal Administrator 21 September 2022 With Editor 20 October 2022 Out for Review 20 October 2022 Decision Pending 26 October 2022 Revision Required 24 November 2022 Revised Manuscript Submitted 24 November 2022 With Journal Administrator 28 November 2022 With Editor 29 November 2022 Out for Review 07 December 2022 Decision Pending 07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向：肿瘤;meta-analysis 经验分享：我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回，我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了，但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：一审三个月，没什么大问题，拖了一个月返回去，二审小修，两天返回，不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;营养 经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=)]

2022-08-25 NGDZTPBCG

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;营养
经验分享：with editor 一个月都已经联系编辑撤回了，等周一编辑上班回复前突然送审了就等着了，20天一审结束返修，2个审稿人都很nice，4天修回。二审一个月，刚接收！夸赞一下这个宝藏杂志，挺好的。编辑都很nice，邮件回复都很及时，沟通很愉快！

100 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务